The debut and course of the neonatal form of propionic aciduria: a clinical case
https://doi.org/10.46563/2686-8997-2023-4-2-104-114
Abstract
Propionic aciduria (PA) is an autosomal recessive hereditary disease from the group of organic aciduria, caused by a deficiency of propionyl-CoA carboxylase, leading to impaired metabolism of methionine, threonine, valine, isoleucine, and fatty acids with an odd number of carbon atoms and cholesterol. The neonatal form of PA manifests itself during the first week of life, is characterized by an acute onset and a crisis course, which is accompanied by severe metabolic acidosis, hypoglycemia, hyperketonemia, hyperammonemia. Clinical symptoms are dominated by neurological disorders up to stupor or coma, which can lead to death. Since 2023, expanded neonatal screening has been introduced throughout the Russian Federation, which includes 36 groups of nosologies, as well as a number of hereditary metabolic diseases. Despite the inclusion of this pathology in expanded neonatal screening, doctors’ awareness of clinical manifestations and necessary therapy remains insufficient. Often such patients are diagnosed with, for example: hypoxic-ischemic damage to the central nervous system, acute meningoencephalitis, and others, which leads to inadequate therapy with the development of fatal neurological consequences. Therefore, the totality of knowledge and alertness of doctors regarding diseases from the group of hereditary metabolic diseases will help not only to suspect this pathology in a timely manner, but also to prescribe adequate therapy in time, which in the future will make it possible to prevent serious consequences and neurological disorders, as well as disability of patients.
Contribution:
Sokolova A.V. — concept, text writing;
Bushueva T.V. — correction diet therapy, concept, text editing;
Kuzenkova L.M. — concept, text writing;
Borovik T.Е. — concept, text writing;
Globa O.V. — concept, text writing;
Podkletnova T.V. — concept, text writing;
Lyalina A.A. — concept, text writing;
Pushkov A.A. — conducting molecular genetic diagnostics, analysis and processing of the results of molecular genetic diagnostics;
Mazanova N.N. — conducting molecular genetic diagnostics, analysis and processing of the results of molecular genetic diagnostics;
Savosl’yanov K.V. — analysis and processing of the results of molecular genetic diagnostics;
Zakharovа E.Yu. — conducting molecular genetic diagnostics, analysis and processing of the results of molecular genetic diagnostics;
Aksyanova K.F. — primary examination, observation of the child at the place of residence;
Khamidova M.M. — design, editing the article;
Khubieva M.U. — design, editing the article.
All co-authors are responsible for the integrity of all parts of the manuscript.
Acknowledgements. The study had no sponsorship.
Conflict of interest. The authors declare no conflict of interest.
Received: May 15, 2023
Accepted: May 26, 2023
Published: June 30, 2023
About the Authors
Angelina V. SokolovaRussian Federation
Junior researcher, Laboratory of healthy and sick child nutrition, neurologist, National Research Center for Children’s Health, Moscow, 119991, Russian Federation.
e-mail: sokolova.av@nczd.ru
Tatiana V. Bushueva
Russian Federation
Lyudmila M. Kuzenkova
Russian Federation
Tatyana Е. Borovik
Russian Federation
Oksana V. Globa
Russian Federation
Tatyana V. Podkletnova
Russian Federation
Anastasiya A. Lyalina
Russian Federation
Alexander A. Pushkov
Russian Federation
Nataliya N. Mazanova
Russian Federation
Ekaterina Yu. Zakharovа
Russian Federation
Khasyanya F. Aksyanova
Russian Federation
Kirill V. Savostyanov
Russian Federation
Madina M. Khamidova
Russian Federation
Mariyam U. Khubieva
Russian Federation
References
1. Chapman K.A., Gramer G., Viall S., Summar M.L. Incidence of maple syrup urine disease, propionic acidemia, and methylmalonic aciduria from newborn screening data. Mol. Genet. Metab. Rep. 2018; 15: 106–9. https://doi.org/10.1016/j.ymgmr.2018.03.011
2. Baumgartner M.R., Hörster F., Dionisi-Vici C., Haliloglu G., Karall D., Chapman K.A., et al. Proposed guidelines for the diagnosis and management of methylmalonic and propionic academia. Orphanet. J. Rare Dis. 2014; 9: 130. https://doi.org/10.1186/s13023-014-0130-8
3. Shchelochkov O.A., Carrillo N., Venditti C. Propionic Acidemia. In: Adam M.P., Mirzaa G.M., Pagon R.A., Wallace S.E., Bean L.J.H., Gripp K.W., eds. GeneReviews. Seattle: University of Washington; 1993–2023.
4. Vernon H.J., Bagnasco S., Hamosh A., Sperati C.J. Chronic kidney disease in an adult with propionic academia. JIMD Rep. 2014; 12: 5–10. https://doi.org/10.1007/8904_2013_237
5. Saudubray J.M., Baumgartner M.R., Walter J. Inborn Metabolic Diseases: Diagnosis and Treatment. Berlin: Springer; 2016.
6. Baranov A.A., Namazova-Baranova L.S., Borovik T.E., Ladodo K.S., Bushueva T.V., Maslova O.I., et al. Diet Therapy for Hereditary Diseases of Amino Acid Metabolism. Methodical Letter [Dietoterapiya pri nasledstvennykh boleznyakh aminokislotnogo obmena. Metodicheskoe pis’mo]. Moscow; 2013. (in Russian)
7. Kör D., Şeker-Yılmaz B., Bulut F.D., Kılavuz S., Öktem M., Ceylaner S., et al. Clinical features of 27 Turkish Propionic acidemia patients with 12 novel mutations. Turk. J. Pediatr. 2019; 61(3): 330–6. https://doi.org/10.24953/turkjped.2019.03.003
8. Kraus J.P., Spector E., Venezia S., Estes P., Chiang P.W., Creadon-Swindell G., et al. Mutation analysis in 54 propionic acidemia patients. J. Inherit. Metab. Dis. 2012; 35(1): 51– 63. https://doi.org/10.1007/s10545-011-9399-0
Review
For citations:
Sokolova A.V., Bushueva T.V., Kuzenkova L.M., Borovik T.Е., Globa O.V., Podkletnova T.V., Lyalina A.A., Pushkov A.A., Mazanova N.N., Zakharovа E.Yu., Aksyanova Kh.F., Savostyanov K.V., Khamidova M.M., Khubieva M.U. The debut and course of the neonatal form of propionic aciduria: a clinical case. L.O. Badalyan Neurological Journal. 2023;4(2):104-114. (In Russ.) https://doi.org/10.46563/2686-8997-2023-4-2-104-114